Upstream Bio, Inc. UPB Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Upstream Bio, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upstream Bio, Inc.'s additional paid-in capital?
- Upstream Bio, Inc. (UPB) reported additional paid-in capital of $678.66M in Q1 2026.
- How has Upstream Bio, Inc.'s additional paid-in capital changed year-over-year?
- Upstream Bio, Inc.'s additional paid-in capital increased by 2.3% year-over-year, from $663.24M to $678.66M.
- What is the long-term trend for Upstream Bio, Inc.'s additional paid-in capital?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s additional paid-in capital has grown at a 1081.5% compound annual growth rate (CAGR), from $4.82M to $673.41M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.